Navigation Links
Essentialis to Submit SPA for Hypertriglyceridemia
Date:8/11/2009

CARLSBAD, Calif., Aug. 11 /PRNewswire/ -- Essentialis, Inc., a clinical stage pharmaceutical company, announced today its intention to file a Special Protocol Assessment (SPA) with the FDA for the pivotal study to support the NDA filing on its lead drug, DCCR, for the treatment of very high triglycerides. The proposed study would include 280 randomized subjects with the primary efficacy endpoint assessed at 12 weeks. This decision followed a productive Type C meeting with the FDA on July 30th, where the overall development plan for DCCR and the non-clinical package supporting the NDA were reviewed and discussed. Commenting on this development, Essentialis President and CEO Iain Dukes stated, "The submission of the SPA will bring us one step closer towards filing for approval of DCCR for the treatment of patients with very high triglycerides. This development, along with positive Phase 2 study results and the recent issuance of a US patent providing extensive protection to DCCR, underscores the tremendous clinical and commercial potential of this drug worldwide."

About DCCR

DCCR, diazoxide choline controlled release tablet, is an ATP-sensitive potassium channel agonist which has potential therapeutic utility in several cardiovascular and metabolic diseases. Extensive Phase 1 testing has demonstrated the drug's potential to lower triglycerides (TG), non-HDL cholesterol and LDL-cholesterol (LDL-C) while raising HDL-cholesterol. In addition, weight loss has been demonstrated in 2 investigator sponsored studies. A Phase 2, 8-week, placebo-controlled, double-blind study involving 90 patients, which was powered to be pivotal, demonstrated statistically significant reductions in triglycerides, without impacting LDL-C. In subjects with elevated LDL-C at baseline, DCCR reduced LDL-C levels. DCCR was generally well tolerated, and most AEs were mild to moderate, resolving without sequelae. US patent 7,57
'/>"/>

SOURCE Essentialis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Essentialis Meets Primary Endpoint in Phase 2b Trial of DCCR for Treatment of Hypertriglyceridemia and is Granted Extensive Patent Coverage in the US
2. Essentialis Completes Patient Enrollment in Phase 2 Trial of DDCR for Treatment of Dyslipidemia
3. Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA
4. Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
5. PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)
6. PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA
7. Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM)
8. Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
9. D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients
10. AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
11. U.S. Naval Medical Research Center Resubmits IND Application for Proposed RESUS Clinical Trial in Trauma Patients in the Out-of-Hospital Setting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... -- Dedicated to promoting wellness and giving back to its ... purple pledge in support of Alzheimer,s & Brain-Awareness Month. ... time to shine a purple light for the millions ... in our community who are affected by Alzheimer,s. Raising ... helps mobilize friends, family members, neighbors and coworkers to ...
(Date:7/7/2015)... -- The Global Breast Pumps Market ... at an estimated CAGR of 7.6% from 2014 to 2020, ... Introduction of innovative technologies including hand free breast pumps, growing ... the advantages of breast milk are expected to drive breast ... of untapped growth opportunities in emerging markets such as ...
(Date:7/7/2015)... , July 7, 2015  Essentialis, a venture-backed company focused ... the treatment of orphan neurobehavioral and metabolic diseases, today announced ... will present a corporate update at the Cantor Fitzgerald Inaugural ... Date: Wednesday, July 8, 2015 Time: 8:00 AM ... About Essentialis, Inc. Essentialis is ...
Breaking Medicine Technology:Purple for a Purpose: Supporting Alzheimer's & Brain-Awareness Month 2Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 2Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 3Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 4
... 10, 2011 The American Society of Bariatric Physicians (ASBP) ...  Our condolences go out to his family, friends and fans. ... phentermine was a contributing factor to his death are concerning ... medications as prescribed. While the specific details ...
... Sciences International, Inc. (Nasdaq: BDSI ) ... study of a formulation of buprenorphine and naloxone ... technology.   (Logo: http://photos.prnewswire.com/prnh/20110217/CL49801LOGO ) ... to select the final doses of BEMA Buprenorphine/Naloxone ...
Cached Medicine Technology:Physicians Who Treat Obesity Respond to the News of Bubba Smith's Overdose 2BioDelivery Sciences Initiates Confirmatory Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone 2BioDelivery Sciences Initiates Confirmatory Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone 3BioDelivery Sciences Initiates Confirmatory Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone 4
(Date:7/7/2015)... ... July 07, 2015 , ... At the end of June Pacific Prime Renewals team in Hong ... This initiative, spearheaded by the Renewals Manager, Danielle Cotton, aims to not only reduce but ... this initiative Cotton explained, “We send anything between 300 and 600 pieces of paper per ...
(Date:7/7/2015)... ... July 07, 2015 , ... Summer is a great time to get ... Insurance is sharing some safety tips. , Jean Tapley, senior wellness coordinator at Amica, ... , Start slowly. Going from no activity to several hours ...
(Date:7/7/2015)... ... ... Healthpointe is proud to announce the addition of Dr. Pedro S. ... will be evaluating and treating patients with orthopedic complaints, such as lumbar back pain ... Science in Biology from the University of the East, Manila, Dr. Alupay earned his ...
(Date:7/7/2015)... , ... July 07, 2015 , ... Parents and guardians ... by A Forever Recovery, an open-ended holistic treatment center for drug and alcohol abuse ... Drug Use and HIV Research has shown a significant increase in the “club drug” ...
(Date:7/7/2015)... ... 07, 2015 , ... FSAstore.com today announced the launch of its ... makes it simple to use, spend and manage HSA funds with innovative tools including ... , According to a report by Devenir , approximately 13.8 million Americans have ...
Breaking Medicine News(10 mins):Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2Health News:Amica Insurance Has 7 Summer Safety Tips 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 3Health News:A Forever Recovery Releases New Information on “Club Drugs” and Tips for Parents of Teens and Young Adults 2Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 2Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 3
... us can recall having difficulty deciphering health information at ... a// prescription too soon because you didn’t understand the ... reading the label on the bottle, low health literacy ... ,Communication problems with health professionals can negatively ...
... who are deprived of company and sad and lonely at the ... stress hormone cortisol in their blood the next morning,// researchers reported ... USA. ,Hormone cortisol is released in the body ... levels also vary through out the day. ,In ...
... states has been infected by a salmonella outbreak according to ... assumed to have spread through some form of produce including ... specific product, chain, restaurants or supermarkets as yet. ... by a common form of salmonella bacteria. Health officials state ...
... Durex best-selling 'extra safe' range were seized in west London ... the company could not 'guarantee the safety' of the fakes. ... UK was also unknown,These counterfeits came to light only after ... the company's laboratories it was confirmed that these were fakes. ...
... have developed a light-emitting sticking plaster, which they claim ... successfully. This// user-friendly device, which can be used by ... light source that is powered by a pocket-sized battery. ... Professor James Ferguson took 4 years to create this ...
... Turmeric the must have spice in every Indian home now ... its potential uses to fight// many tubborn inflammations and degenerative ... the ancient scripts of Ayurveda. ,According to a ... Medicine by Janet L. Funk, MD, working with Barbara N. ...
Cached Medicine News:Health News:Low Health Literacy Interferes with Good Health Care 2Health News:Salmonella Outbreak under Investigation 2Health News:Innovative treatment for Skin Cancer 2
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Rad-5 signal extraction pulse oximeter™...
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
Medicine Products: